Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_2
1
20%
Ph phase_1
3
60%

Phase Distribution

3

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 2Efficacy & side effects
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Other(1)

Detailed Status

Completed4
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (75.0%)
Phase 21 (25.0%)

Trials by Status

unknown120%
completed480%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_1

Study of the Safety of Intravenous Artesunate

NCT00292942
completedphase_1

Phase I Study of Intravenous Artesunate for Solid Tumors

NCT02353026
completedphase_1

Study of the Safety of Intravenous Artesunate

NCT00292929
completedphase_2

Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malaria

NCT02492178
unknown

Pharmacokinetics and Pharmacodynamics of Intravenous Artesunate for Severe Malaria Treatment

NCT01122134

Clinical Trials (5)

Showing 5 of 5 trials
NCT00292942Phase 1

Study of the Safety of Intravenous Artesunate

Completed
NCT02353026Phase 1

Phase I Study of Intravenous Artesunate for Solid Tumors

Completed
NCT00292929Phase 1

Study of the Safety of Intravenous Artesunate

Completed
NCT02492178Phase 2

Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malaria

Completed
NCT01122134

Pharmacokinetics and Pharmacodynamics of Intravenous Artesunate for Severe Malaria Treatment

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5